Oz Healthcare Communications appointed by Novartis 12 Feb 200812 Feb 2008 WhatsappPrintPDFOz Healthcare Communications have added another account to their portfolio of global pharmaceutical brands with the addition of Aclasta (zoledronic acid) from Novartis.